AUSTRALIA
The 2023 Pharmaceutical Patent Review
Welcome to Spruson & Ferguson’s wrap-up of the most notable developments in pharmaceutical patent law in Australia in 2023. The past year saw a number of important Federal Court...
Welcome to Spruson & Ferguson’s wrap-up of the most notable developments in pharmaceutical patent law in Australia in 2023....
Read More
AUSTRALIA
Wait times to patent examination and how to influence them
In Australia, the time between requesting examination of a patent application and receipt of an Examination Report (ER) can take longer than the 12-month period targeted by IP Australia,...
In Australia, the time between requesting examination of a patent application and receipt of an Examination Report (ER) can...
Read More
AUSTRALIA
Trade Mark Classification of Virtual Goods and NFTs in Australia
Following on from our recent article regarding NFTs, the complicated relationship with real-world products, and trade marks office practices, on 10 August 2023, IP Australia released new guidance on...
Following on from our recent article regarding NFTs, the complicated relationship with real-world products, and trade marks office practices,...
Read More
AUSTRALIA
No pay day for Commonwealth in Sanofi pharmaceutical damages claim
Background In the keenly awaited judgment in Commonwealth of Australia v Sanofi (formerly Sanofi-Aventis)  FCAFC 97, the Full Court of the Federal Court of Australia has upheld the trial judge’s decision that...
Background In the keenly awaited judgment in Commonwealth of Australia v Sanofi (formerly Sanofi-Aventis)  FCAFC 97, the Full Court of the Federal...
Read More
AUSTRALIA
To boil, or not to boil, that is the (infringement) question
A recent decision (Calix Limited v Grenof Pty Ltd) from the Federal Court of Australia provides a cautionary tale to patent applicants and patent attorneys regarding the complexities in...
A recent decision (Calix Limited v Grenof Pty Ltd) from the Federal Court of Australia provides a cautionary tale...
Read More
AUSTRALIA
Spruson & Ferguson expands Melbourne team with new appointments
Spruson & Ferguson is pleased to welcome three new practitioners to the firm’s Melbourne office: Michelle Blythe, Jarrod Lichtblau, and Willem du Preez. Michelle and Jarrod have joined the team...
Spruson & Ferguson is pleased to welcome three new practitioners to the firm’s Melbourne office: Michelle Blythe, Jarrod Lichtblau,...
Read More
AUSTRALIA
Important changes to management of Australian divisional patent applications
What is a divisional patent application? A divisional patent application may be filed to divide a patent application into two or more patent applications from a "parent" application. The divisional...
What is a divisional patent application? A divisional patent application may be filed to divide a patent application into two...
Read More
AUSTRALIA
Spruson & Ferguson recognised in WTR 1000 2023
Spruson & Ferguson are pleased to once again be included in the WTR 1000 2023, with five jurisdiction listings and 10 recommended individuals featured. Spruson & Ferguson has been ranked...
Spruson & Ferguson are pleased to once again be included in the WTR 1000 2023, with five jurisdiction listings...
Read More
AUSTRALIA
Dr Mike Zammit appointed leader of Chemical/Life Sciences team in Australia
Spruson & Ferguson is pleased to announce the appointment of Dr Mike Zammit as its new Chemical/Life Sciences Practice Group Leader in Australia. Mike joined Spruson & Ferguson in October...
Spruson & Ferguson is pleased to announce the appointment of Dr Mike Zammit as its new Chemical/Life Sciences Practice...
Read More

Find Your Expert

Experts

Contact Us

Enquiries

Receive Insights

Subscribe